Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 31-38 of 38

Page
per page
  1. Raltegravir (MK-0518)
    A4073 Raltegravir (MK-0518)
     1 Citation
    Target: integrase
    Summary: HIV-1 integrase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
  2. Telaprevir (VX-950)
    A4031 Telaprevir (VX-950)
    Target: HCV NS3-4A protease
    Summary: HCV NS3-4A protease inhibitor
      ≥32.95 mg/mL
  3. Norfloxacin
    B1801 Norfloxacin
    Target: Topoisomerases
    Summary: Topoisomerase inhibitor
      insoluble in H2O; insoluble in DMSO; insoluble in EtOH
  4. Didanosine
    A8410 Didanosine
    Target: Reverse Transcriptases
    Summary: Reverse transcriptase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥23.61 mg/mL
  5. Emtricitabine
    A8422 Emtricitabine
     1 Citation
    Target: Reverse Transcriptases
    Summary: Reverse transcriptase inhibitor
      ≥10.4 mg/mL
  6. Aprepitant
    A1684 Aprepitant
    Target: Substance P/NK1 Receptor
    Summary: Substance P (SP) inhibitor
      ≥26.72 mg/mL
  7. Fluorouracil (Adrucil)
    A4071 Fluorouracil (Adrucil)
     3 Citation
    Target: Thymidylate Synthase
    Summary: Antitumor agent;inhibitor of thymidylate synthase
      insoluble in EtOH; ≥10.04 mg/mL
  8. Cidofovir
    A5790 Cidofovir
    Target: CMV
    Summary: Anti-CMV drug;inhibitor of viral DNA syntheis
      insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL

Items 31-38 of 38

Page
per page